Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
24th November 2020 | James J Marino | 38,774 | Open or private purchase | $0.26 | $10,003.69 |
11th June 2020 | Diane C. Young | 2,115 | Open or private purchase | $4.73 | $10,003.95 |
10th June 2020 | Sarah Cavanaugh | 1,050 | Open or private purchase | $4.83 | $5,071.50 |
9th June 2020 | Tibor Keler | 5,000 | Open or private purchase | $2.99 | $14,954.00 |
9th June 2020 | Margo Heath Chiozzi | 1,000 | Open or private purchase | $3.01 | $3,005.00 |
9th June 2020 | Samuel Bates Martin | 9,750 | Open or private purchase | $3.05 | $29,737.50 |
9th June 2020 | James J Marino | 8,305 | Open or private purchase | $3.00 | $24,915.00 |
9th June 2020 | Anthony S Marucci | 15,000 | Open or private purchase | $3.06 | $45,900.00 |
25th November 2019 | James J Marino | 150,000 | Open or private purchase | $0.20 | $30,000.00 |
25th September 2019 | James J Marino | 7,260 | Open or private purchase | $1.60 | $11,616.00 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
Celldex Therapeutics, Inc. engages in the research, development, and commercialization of immunotherapies and other targeted biologics. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases. The company was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.
1st December 2020
23rd November 2020